Previous 10 | Next 10 |
Gainers: NAVI +6.4% . NNVC +5.7%. IBM +4.3% . EXPR +4.1% . SPCE +3.1% . More news on: Navient Corporation, NanoViricides, Inc., International Business Machines Corporation, Stocks on the move, , Read more ...
The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with this Read more ...
Gainers: XPO +15.6% . OSMT +15.1% . SYRS +3.1% . SAVE +2.1% . CRSP +1.9% . More news on: XPO Logistics, Inc., Osmotica Pharmaceuticals plc, Syros Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 15, 2020. Chirag Patel, Amneal’s Co-Chief Executive Officer ...
Point Roberts, WA and Delta, BC - December 20, 2019 (Investorideas.com Newswire) Investorideas.com , a global news source and investor resource covering cannabis and hemp stocks announces this week's additions to its cannabis /hemp stock directory for investors following the sector. This we...
Point Roberts, WA and Delta, BC - December 20, 2019 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in tech and biotech. This week's news companies are all Decemb...
December 17, 2019 Palm Beach, FL –December 17, 2019 – The success rate for cancer therapies has been limited due to a combination of factors, such as the treatment/drug’s lack of penetration through the blood brain barrier. Reports say that the global drug d...
Three Independent Directors Bring Significant Pharmaceutical, Healthcare and Financial Expertise and Track Records of Creating Value for Shareholders Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that Jeff George, John...
Gainers: Amneal Pharmaceuticals (NYSE: AMRX ) +49% . More news on: Amneal Pharmaceuticals, Inc., Diebold Nixdorf, Incorporated, Assembly Biosciences, Inc., Stocks on the move, Read more ...
Amneal Pharmaceuticals (NYSE: AMRX ) +32% as FDA OKs Amneal ANDA for EluRyng. More news on: Amneal Pharmaceuticals, Inc., LMP Automotive Holdings, Inc., Pintec Technology Holdings Limited, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NASDAQ Market:
Amneal Pharmaceuticals Inc. Class A Website:
First presentation of preservative-free potassium phosphates in a single-dose IV infusion bag Third 505(b)(2) injectable added this year – will launch in third quarter Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) to...
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its second quarter 2024 financial results on Friday, August 9, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. ...
FOCINVEZ (fosaprepitant) 150 mg/50 mL single dose vial is an anti-nausea agent for highly emetogenic and moderately emetogenic chemotherapy (HEC and MEC) Second injectable RTU product launched by Amneal in 2024 Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal”...